Trial intelligence / Profile preview

Exenatide in Extreme Pediatric Obesity

NCT01237197Phase 2Completed

Sponsor
University of Minnesota
Start
Oct 2010
Primary completion
May 2012
Countries
1
01

Overview

A Phase 2 trial of exenatide in obesity, sponsored by University of Minnesota. Started Oct 2010; status: completed.

02

Drugs

exenatide
03

Conditions

obesity

Beyond the preview

Go deeper on NCT01237197.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01237197.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call